Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
14%
ALSO IN IDNA
IDNA
44
HOLDINGS
11%
ALSO IN PBE
SECTOR DRIFT (PBE minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
INCYTE CORP | 4.8% | 4.9% | 4.8% |
|
REGENERON PHARMACEUTICALS | 4.8% | 5.1% | 4.8% |
|
EXELIXIS INC | 2.7% | 3.3% | 2.7% |
|
BIOCRYST PHARMACEUTICALS INC | 2.1% | 2.1% | 2.1% |
PBE Overweight Relative to IDNA
|
BIOGEN IDEC INC | 5.5% |
|
VERTEX PHARMACEUTICALS INC | 4.9% |
|
ILLUMINA INC | 4.8% |
|
AMGEN INC | 4.8% |
|
ROYALTY PHARMA PLC CLASS A | 4.7% |
|
GILEAD SCIENCES INC | 4.6% |
|
IONIS PHARMACEUTICALS, INC. | 4.2% |
|
UNITED THERAPEUTICS CORP | 3.7% |
|
PTC THERAPEUTICS INC | 3.4% |
|
SAREPTA THERAPEUTICS INC | 3.2% |
PBE Underweight Relative to IDNA
|
REVOLUTION MEDICINES, INC. | -6.1% |
|
CELCUITY INC. | -5.7% |
 |
GENMAB A/S | -4.6% |
|
MERCK & CO. INC. | -4.3% |
 |
ASTRAZENECA PLC | -4.1% |
 |
ROCHE HOLDING LTD | -3.8% |
|
GSK PLC | -3.7% |
|
ARCELLX, INC. | -3.4% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
SANOFI-AVENTIS | -3.2% |